We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRS icon
6551
Stratus Properties
STRS
$163M
$16K ﹤0.01%
539
+197
+58% +$5.76K
TLYS icon
6552
Tilly's
TLYS
$121M
$16K ﹤0.01%
1,412
+515
+57% +$5.37K
VIRC icon
6553
Virco
VIRC
$96.1M
$16K ﹤0.01%
+2,995
New +$16.3K
VYGR icon
6554
Voyager Therapeutics
VYGR
$180M
$16K ﹤0.01%
+771
New +$8.7K
WOLF icon
6555
CALL
Wolfspeed
WOLF
$1.31B
$16K ﹤0.01%
576
-1,224
-68% -$30.5K
RNTX
6556
Rein Therapeutics
RNTX
$63M
$16K ﹤0.01%
+58
New +$14.5K
SYRS
6557
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$16K ﹤0.01%
110
+29
+36% +$5.45K
SNAX
6558
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$16K ﹤0.01%
107
+54
+102% +$8.2K
TRHC
6559
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$16K ﹤0.01%
585
+470
+409% +$8.97K
FFHG
6560
DELISTED
Formula Folios Hedged Growth ETF
FFHG
$16K ﹤0.01%
+600
New +$15K
IDEX
6561
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$16K ﹤0.01%
+48
New +$10.7K
HBMD
6562
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$16K ﹤0.01%
808
+111
+16% +$2.17K
MRLN
6563
DELISTED
Marlin Business Services Corp
MRLN
$16K ﹤0.01%
547
+487
+812% +$12.7K
CBMG
6564
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$16K ﹤0.01%
1,507
+1,376
+1,050% +$13K
TCCO
6565
DELISTED
Technical Communications Corporation
TCCO
$16K ﹤0.01%
+2,925
New +$16K
GMO
6566
DELISTED
General Moly, Inc.
GMO
$16K ﹤0.01%
40,362
+38,862
+2,591% +$16.4K
ANFI
6567
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$16K ﹤0.01%
2,649
+2,048
+341% +$11.7K
XINA
6568
DELISTED
SPDR MSCI China A Shares IMI ETF
XINA
$16K ﹤0.01%
680
CBK
6569
DELISTED
Christopher & Banks Corporation
CBK
$16K ﹤0.01%
12,316
+1,852
+18% +$2.56K
CIVI
6570
DELISTED
Civitas Solutions, Inc.
CIVI
$16K ﹤0.01%
857
+703
+456% +$12.8K
ZIONZ
6571
DELISTED
Zions Bancorporation N.A. Warrants
ZIONZ
$16K ﹤0.01%
1,400
+900
+180% +$9.31K
ENTL
6572
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$16K ﹤0.01%
906
-3,694
-80% -$64K
OAPH
6573
DELISTED
OShares FTSE Asia Pacific Quality Dividend Hedged ETF
OAPH
$16K ﹤0.01%
578
+577
+57,700% +$16.4K
EMKR
6574
DELISTED
Emcore Corp
EMKR
$16K ﹤0.01%
198
+38
+24% +$3.68K
SZO
6575
DELISTED
DB Crude Oil Short Exchange Traded Notes due June 1, 2038
SZO
$16K ﹤0.01%
191
-25
-12% -$2.35K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.